Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and Liraglutide in Adults with Overweight or Obesity without Diabetes: A Comparative Study.

Diabetes Metab Syndr Obes · 2026 · PMC13050166 · PMID 41938643

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

The proportion of patients achieving very high weight loss (>25%) was numerically greater in the tirzepatide group than in the other treatment groups; however, this difference did not reach statistical significance (p > 0.05) ( Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.